Over 800 medicines were sold and used during the year!

On December 9, the State Food and Drug Administration issued an announcement on the cancellation of 210 drug registration certificates including chloramphenicol tablets (No.
149 of 2021), which attracted the attention of the industry
.
According to the list of cancelled drug registration certificates, the cancelled drugs include 0.
25g chloramphenicol tablets, 0.
1g norfloxacin capsules, 0.
2g metronidazole tablets and other 210 drugs, involving Sinopharm Xinjiang Pharmaceutical Co.
, Ltd.
, Kangchen Pharmaceutical (Inner Mongolia) Co.
, Ltd.
and other 26 companies
.
Judging from the cancellation situation, these more than 200 drugs are all cancelled in accordance with the application
.
Since the beginning of this year, the State Food and Drug Administration has issued multiple announcements on the cancellation of drug registration certificates.
According to the author's incomplete statistics, as of now, a total of 805 drug registration certificates have been cancelled since the beginning of the year
.
On November 15, the State Food and Drug Administration issued an announcement on the cancellation of the registration certificates of 8 types of medicines including Xiaoerfenaminokamin granules (No.
138 of 2021).
After the launch of 8 varieties, such as, aminopyrine tablets, compound aminopyrinyl theophylline tablets, amrinol capsules, aminocamin tablets, bufenac cream, children's compound aspirin tablets, and amphipine tablets, etc.
Evaluation
.
After evaluation, the State Drug Administration has decided to stop the production, sale, and use of the above-mentioned eight varieties in China from today, and cancel the drug registration certificate
.
On August 25th, the State Food and Drug Administration issued an announcement on the cancellation of registration certificates for 46 drugs including Lincomycin Hydrochloride Capsules (No.
104 of 2021).
According to the list of cancelled drug registration certificates, among the 46 drugs whose drug certificates were cancelled, There is no shortage of imported products, such as Novartis's protamine-human insulin mixed injection (50R), protamine biosynthetic human insulin injection (pre-mixed 50R), etc.
, and from the perspective of cancellation, they are all cancelled upon application
.
On June 16, the State Food and Drug Administration issued an announcement on the cancellation of registration certificates for 42 drugs including glucose injection (No.
83 of 2021).
From the list of the cancellation of drug registration certificates, these 42 drugs include glucose injection and coptis Common varieties such as Shangqing Pills and Liuwei Dihuang Pills.
The holders of the drug marketing authorization involved are all local pharmaceutical companies, and they are all cancelled upon application.

.
On May 19, the State Food and Drug Administration issued an announcement on the cancellation of registration certificates of 283 drugs including megestrol acetate dispersible tablets (No.
70 in 2021).
From the list, these 283 drugs include megestrol acetate Dispersible tablets, simvastatin tablets, levofloxacin hydrochloride capsules, analgin tablets, etc.
, involving companies such as Changzhou Huasheng Pharmaceutical, Conba Pharmaceuticals, etc.
, have also been cancelled upon application
.
On February 23, the State Food and Drug Administration issued an announcement on the cancellation of 226 drug registration certificates including bromelain enteric-coated tablets (No.
27 of 2021).
This time, there are a total of bromelain enteric-coated tablets, finasteride tablets, and Cato The cancellation of registration certificates for drugs such as Puli Tablets and Ranitidine Hydrochloride Capsules includes cancellation or no re-registration upon application
.
From the perspective of the industry, in recent years, driven by a series of medical reform policies such as centralized procurement, consistency evaluation, and medical insurance control fees, the domestic pharmaceutical market environment has continued to change, and the competition between drugs is fierce.
Eliminated out
.
From the perspective of deregistration, most pharmaceutical companies apply for deregistration independently, which shows that the market reshuffle is intensifying
.